Familial clustering of autoimmune thyroid diseases has led to studies of their association with human major histocompatibility complex (MHC) class II genes. One such gene implicated in Hashimoto's thyroiditis (HT) is HLA-DR3, but the association is weak and is contradicted by other reports. On the other hand, murine experimental autoimmune thyroiditis (EAT), a model for HT, presents a clear linkage with MHC class II. Moreover, it is inducible with thyroglobulin (Tg), the common autoantigen in either species. Immunization of HLA-DRBI*0301 (DR3) transgenic mice with mouse or human Tg resulted in severe thyroiditis. In contrast, transgenic mice expressing the HLA-DRBI*1502 (DR2) gene were resistant to EAT. Our studies show that HLA-DRB1 polymorphism determines susceptibility to autoimmune thyroiditis and implicate Tg as an important autoantigen.
A
well known model for Hashimoto's thyroiditis (HT) is murine experimental autoimmune thyroiditis (EAT). Susceptibility to this T cell-mediated disease is linked to H2A class II molecules of the routine major histocompatibility complex (MHC), which can present thyroiditogenic, highly conserved T cell epitopes on thyroglobulin (Tg) from both the mouse (M) and human (H) (1, 2) . In contrast with studies on EAT, patient studies over the past 15 yr have not revealed a clear HLA association with HT despite improved typing techniques, although it is clear that ethnic variations exist. Several studies in Caucasians have implicated both DRBI*0301 (DR3) and DRBl*11011 (DR5) (3) (4) (5) (6) (7) (8) . However, a negative association with DR3 (9) or lack of any DR region association has also been reported (10) (11) (12) . Recently, certain HLA-DQ alleles have also been implicated, even though the associations are complicated by linkage disequilibrium with DR loci. For instance, while the DQBI*0201 (DQw2) gene has been implicated in HT, its involvement is questionable owing to linkage with DR3 (6, 8, 13) . Using HLA-DR and HLA-DQ transgenic mice, we can address the specific role of each HLA class II gene in human thyroid disease. We report here that EAT is induced in HLA-DR3 (DRBI*0301) transgenic mice immunized with either MTg or HTg, an autoantigen also in the human. In contrast, DRB1*1502 (DR2) transgenic mice were unresponsive to MTg. Thus, DRBI polymorphism is a determining factor in susceptibili W to autoimmune thyroiditis.
Materials and Methods
Tgs and Adjuvant. MTg and HTg from frozen thyroids were fractionated on a Sephadex G-200 column (Pharmacia Biotech Inc., Piscataway, NJ) and checked for purity by immunoelectrophoresis as detailed previously (14) . Salmonella enteritidis LPS was prepared by TCA precipitation.
Generation of HLA-DRB1 Transgenic Mice. The generation of DRBI*0301 (DR3) transgenic mice by coinjection of an HLADRoL genomic fragment and a DRB1*030113 gene fragment into (C57BL/6 • DBA/2)F 1 • C57BL/6 embryos and backcross to B10 mice was detailed previously (15) . In the specific pathogenfree facility at Mayo Clinic, the DR3 transgene was first introduced into B10.M mice by repeated backcrossing. Subsequently, the DR3 gene was introduced into the class II-negative H2Ab ~ strain (16) by mating the B10.M-DRBI*0301 line with the B10.Ab ~} line, similar to the strategy detailed recently for HLA-DQ transgenic mice (17) . PBLs were typed for expression and segregation during breeding by flow cytometry using the following monoclonal Abs: L227, anti-DRB1 (18); AF6-120, anti-H2A b (19); 28-14-8S, anti-H2D b (20); 14-4-4S, anti-H2E (21); 3F-12, anti-H2A t (22) . DRBl*1502.Ab ~ (HLA-DR2, H2Ab ~ transgenic mice were generated as detailed elsewhere (23 Thyroid inflammation was determined histologically from 30-60 sections (7-10 step levels) containing both thyroid lobes, and the percentage of mononuclear cell infiltration and destruction in individual mice was recorded (26) . Thyroids with > 10% involvement showed definite follicular destruction accompanying focal areas of infiltration.
In Vitro Prolferation. Cellular proliferation was carried out as detailed previously (26, 27) . In brief, on day 28 after immunization with MTg or HTg, spleen cells (SCs) were cultured for 4 or 5 d in flat-bottomed, 96-well plates (6 • 105 cells per well) with 40 btg/ml of either Tg. For blocking of Ag presentation, HLAspecific and control mAbs were added to cells at the concentrations indicated in the legend, with or without Tg. Culture medimn consisted of P, PMI 1640 medium with 25 mM Hepes buffer, supplemented with 2 mM glutamine, 100 U/ml penicillin, 100 Ixg/ml streptomycin (all from GIBCO BRL, Gaithersburg, MD), 50 p.M 2-ME (Sigma Chemical Co., St. Louis, MO), and 1% normal mouse serum. After pulsing with 1.2 b~Ci of [3H]thymidine (ICN Biomedicals, Inc., Costa Mesa, CA) for the find 18 h, the ceils were harvested on glass fiber filters.
[3H]Thymidine uptake in triplicate cultures was determined in an LKB-Wallac liquid scintillation counter (LKB-Wallac, Turku, Finland).
Results and Discussion

BIO.M-DR3 + Transgenic Mice Are Susceptible to EAT.
Initial DR3 gene transfer experiments were conducted in EAT-resistant B10.M mice after mating with DRBI*0301 transgenic mice and backcrossing to B10.M mice. Immunization with either MTg or HTg resulted in thyroid inflammation in the B10.M-DRBI*0301 mice (Table 1) . Marked infiltration of mononuclear cells and destruction involving up to 40% of both thyroid lobes were present in 80% of MTg-immunized DR3 + mice, compared with none in the Table 1 for experimental protocol. *Class lI-negative H2Ab" control mice.
D R 3 -sibs, which remained resistant. In H T g -i m m u n i z e d mice, all the D R 3 + mice displayed similarly typical inflammation o f > 1 0 -4 0 % . The D R 3 -mice were essentially negative; a focal perivascular infiltration in two mice could be due to a low response mediated by endogenous H2A molecules. In addition to conserved epitopes shared between M T g and HTg, H T g contains foreign epitopes that are known to stimulate T and B cells of both EAT-susceptible and EAT-resistant mice (26, 27) . Thus, in Fig. 1 , both D R 3 + and D R 3 -mice responded strongly and comparably to H T g in both in vitro proliferative response and anti-H T g production, in contrast with the differential response to MTg. These data show that the D R 3 transgene renders a resistant strain susceptible to EAT induction by either M T g or HTg.
DR3.Ab ~ Mice Are Susceptible to EAT.
To define the extent of D R 3 influence in EAT susceptibility, the D R 3 transgene was introduced into H2Ab ~ mice, the class I Inegative strain, by mating with B10.M-DRBI*0301 mice. The Ec~ k transgene (Ab~ k) was introduced into some mice to compete with the pairing between the DRot molecule and the endogenous El3 b molecule and to determine a role for Eot and E~ chains. These mice do not express any H2A molecules. Initial experiments on E A T induction with M T g not only showed that EAT was induced in DRBI*0301.Ab ~ mice, but also that expression of the EB b molecules played no role. Table 2 presents typical data from such M T g -i m m u n i z e d groups. Severe thyroiditis involving up to 80% o f the gland was observed in all the animals from both D R 3 + groups regardless of E[3 b expression (Fig. 2 A) . The presence o f the EJ3 b molecule in D1K3-mice did not result in thyroiditis (see also Table 3 ). The D R 3 transgene in the E -A b ~ mice also responded to H T g immunization with 83% incidence of thyroid inflammation Table 1 for experimental protocol.
averaging 30% of the gland (Fig. 2 /3 ). In both MTg-and HTg-immunized mice, high anti-MTg Ab titers (detectable at 1:800 dilution) were observed only in DR3 + mice (anti-HTg titers tested separately).
DR2.Ab ~ Mice Are Resistant to EAT.
The role of HLA-DRB1 polymorphism in susceptibility to thyroiditis was tested with HLA-DR2 transgenic mice. The DRB1-"1502.Ab ~ (DR2Dw12) mice were generated by mating positive founder mice with class II-negative Ab {J mice as well as EoL k transgenic mice. After MTg immunization, all DR2 + mice displayed resistance to EAT, in contrast with DR3 + mice, which exhibited marked to severe thyroid inflammation (Table 3) . A repeat experiment with DR2+E + (seven mice) and DR2-E + (six mice) groups immunized with MTg also revealed no significant thyroid involvement, compared with all nine DR3 + mice with thyroiditis (data not shown). In both experiments, the anti-MTg titers in DR2 + mice were undetectable at 1:800 dilution. Upon 
Lymphocyte Proliferation to Tg is CD4 + T Cell-mediated and DR3-restricted.
The function of DR3 molecules in vivo as classic Ag presenters during EAT induction was verified by in vitro blocking studies with mAbs to DRcr and I)RB1 and appropriate control mAbs. Fig. 3 shows that the proliferative responses to MTg of primed SCs were blocked by both mAbs, reducing the response to near background levels of cells plus only mAb in the absence of MTg. In Fig. 3 A, a rat mAb to mouse CD4 served as positive control for blocking MTg proliferation (28) . The abrogation of T cell proliferative response by anti-DR~ in DR3+E + mice confirms that pairing of DRotDR~ is preferred. In Fig. 3 B, Ag presentation was not blocked by anti-D b, a control anticlass I mAb. More importantly, proliferation was not affected by anti-E[~ b, indicating that DRotE~ pairing was minimal and not involved in MTg-priming. Similarly, the proliferative response to HTg of SCs from HTg-mmmnized D1K3 + mice was inhibited by mAbs to either DRot or DRB1 (data not shown).
In conclusion, our findings demonstrate an important role for the HLA-DR3 gene in susceptibility to HT. The conflicting reports on HT and DR3 association mentioned earlier are complicated by low relative risk (2.2-3.5), link-age disequilibrium with other genes such as DQw2 and HLA-B8 (3, 5, 8) , unknown modifying background genes, and different typing techniques. On the other hand, our transgenic mice express uniform background genes with specific HLA class II genes. Our evidence associating DR3 and dissociating DR2 from EAT underscores the usefulness of this DRB1 transgenic model to pinpoint the involvement of particular HLA genes in HT. The DR3 association in autoimmune thyroiditis induced by either HTg or MTg also demonstrates the importance of Tg as a thyroid autoantigen, possibly involved in human pathogenesis rather than just as a diagnostic tool to be replaced by thyroperoxidase, the microsomal Ag. Our data suggest that the longtime usage of Tg as a model antigen in murine EAT has real relevance. The use of a humanized model should identify potential Tg epitopes involved in human disease. As more HLA transgenic mice become available, the importance of other class II genes, such as DQ, and other thyroid Ags may be learned.
